Prescription drug · ANDA
Perphenazine NDC 23155-801
Perphenazine 8 mg/1 · Tablet · Oral · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 23155-801-01 | 23155080101 | 100 TABLET in 1 BOTTLE (23155-801-01)Marketed from Oct 1, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Perphenazine
- Generic name (nonproprietary)
- perphenazine
- Active ingredients
- Perphenazine — 8 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210163
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 23155-801_4cc7f39f-fa21-4dc0-8ff7-5d6e5a7236a2SPL ID 4cc7f39f-fa21-4dc0-8ff7-5d6e5a7236a2SPL set ID 935a7567-0395-4901-960c-79587fa14c8dRxCUI 198075, 198076, 198077, 198078UNII FTA7XXY4EZUPC 0323155800012
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N423155080101followed by a unit qualifier and the quantityPackage 23155-0801-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE: Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 210163
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Perphenazine | Perphenazine 4 mg/1 | TabletOral | Chartwell RX, LLC | 62135-799 |
| Perphenazine | Perphenazine 2 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-799 |
| Perphenazine | Perphenazine 4 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-800 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-802 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4144 |